World Digestive Health Day 2026 and the need for faster IBD diagnosis and care
Each year, the World Gastroenterology Organisation (WGO) marks World Digestive Health Day (WDHD) by launching a public health campaign to improve overall awareness of digestive health, as well as the prevalence, diagnosis, treatment and prevention of digestive disorders. WDHD 2026 takes place on Friday the 29th of May, with the campaign ‘Chronic Diarrhoea: Don’t Flush the Signs Away’. This year’s theme highlights the importance of recognising chronic diarrhoea symptoms, which remain widely misunderstood and underreported, despite being an early warning sign of serious underlying disease. While chronic diarrhoea can be linked to a range of conditions, inflammatory bowel disease (IBD) offers a clear example of why these symptoms need to be taken seriously, with delays in diagnosis and care often having a lasting impact on patients’ lives.
Chronic diarrhoea symptoms and the stigma of seeking help
Research by the charity Guts UK has shown that 58 % of people are embarrassed to discuss their digestive condition and symptoms, and 51 % delay seeking medical advice for gastrointestinal problems for over six months. For many patients, this perceived stigma and embarrassment leads to delayed diagnoses, meaning they may spend months or years struggling with symptoms. The day-to-day impact of untreated gastrointestinal symptoms like urgency, fatigue and abdominal pain can have severe impacts on work, relationships and mental wellbeing.
This delay is not just a patient burden, but adds to the diagnostic workloads of their primary care teams, as well as specialist gastroenterology services. By the time many people enter the healthcare system, symptoms can be persistent, complex or worsening, placing greater pressure on services that are often already struggling to provide timely investigations.
Why IBD diagnosis pathways remain challenging in the UK
Once patients do seek help, they can face further barriers on the NHS pathway towards a clear diagnosis. Many gastrointestinal diseases share overlapping symptoms, which can make it difficult to distinguish between functional disorders, infections and inflammatory diseases like IBD. Where non-invasive or point-of-care tests are not routinely used to enable early triage, patients may face long waits for invasive procedures like endoscopies and biopsies. In many parts of the UK, endoscopy services are overstretched and under resourced, adding to the delay. In the case of IBD, long waiting times can allow inflammation to progress further, worsening both physical health and emotional wellbeing.
The challenge of long-term IBD care in the UK
For many patients, receiving an IBD diagnosis is only the start of a long and often unpredictable healthcare journey. Advances in treatment, particularly the introduction of new biologic therapies, and improved disease monitoring have improved outcomes for some patients. However, access to consistent and proactive care across the UK remains uneven. In some areas, patients are trapped in reactive care pathways, with support only available once symptoms worsen. Regular hospital appointments, combined with delays in accessing specialist teams, can cause significant stress for patients, adding to the burden of those living with disease.
Building a more patient-centred future for IBD care
Despite ongoing challenges in diagnosis and long-term management, there are opportunities to improve the experience for patients living with IBD and their care teams. Technological advances in POCT, remote monitoring and therapeutics have significantly improved the lives of patients with the disease, while changes in healthcare policy and a shift towards patient-led disease management have helped to reduce unnecessary hospital visits. Together, these improvements make it easier for many patients to balance management of their condition with work, education and everyday life.
However, technology alone will not solve the wider issues affecting digestive healthcare in the UK. Earlier diagnosis, faster access to specialist support and better public awareness of chronic diarrhoea symptoms are essential to improving outcomes. As WDHD 2026 highlights, digestive symptoms should never be ignored or dismissed due to perceived stigma or embarrassment. Improving outcomes for people living with conditions like IBD will depend not only on innovations in treatment and monitoring, but also on creating healthcare pathways where patients feel comfortable in seeking help early, and confident that their symptoms will be taken seriously.
Learn more about how home calprotectin testing is supporting better IBD monitoring.
